Which has better valuation & earnings, ZTF or VCT?

Victrex has higher revenue and earnings than Zotefoams. Victrex is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zotefoams £176.29M 1.21 £9.80M £44.87 9.69 Victrex £296.40M 2.43 £30.80M -£22.40 N/A

Is ZTF or VCT more profitable?

Zotefoams has a net margin of 14.28% compared to Victrex's net margin of -6.70%. Zotefoams' return on equity of 18.25% beat Victrex's return on equity. Company Net Margins Return on Equity Return on Assets Zotefoams 14.28% 18.25% 5.48% Victrex -6.70% -4.95% 6.59%

Does the media prefer ZTF or VCT?

In the previous week, Zotefoams had 8 more articles in the media than Victrex. MarketBeat recorded 9 mentions for Zotefoams and 1 mentions for Victrex. Zotefoams' average media sentiment score of 0.40 beat Victrex's score of 0.00 indicating that Zotefoams is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zotefoams 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Victrex 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate SCPA or ZTF?

Zotefoams has a consensus price target of GBX 605, suggesting a potential upside of 39.08%. Given Zotefoams' stronger consensus rating and higher probable upside, analysts plainly believe Zotefoams is more favorable than Scapa Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Scapa Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Zotefoams 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has preferable valuation & earnings, ZTF or ESNT?

Zotefoams has higher earnings, but lower revenue than Essentra. Zotefoams is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zotefoams £176.29M 1.21 £9.80M £44.87 9.69 Essentra £315.70M 1.02 £3.50M £2.50 45.28

Is ZTF or ESNT more profitable?

Zotefoams has a net margin of 14.28% compared to Essentra's net margin of 1.71%. Zotefoams' return on equity of 18.25% beat Essentra's return on equity. Company Net Margins Return on Equity Return on Assets Zotefoams 14.28% 18.25% 5.48% Essentra 1.71% 2.02% 1.74%

Does the media favor ZTF or ESNT?

In the previous week, Zotefoams had 8 more articles in the media than Essentra. MarketBeat recorded 9 mentions for Zotefoams and 1 mentions for Essentra. Zotefoams' average media sentiment score of 0.40 beat Essentra's score of 0.36 indicating that Zotefoams is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zotefoams 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Essentra 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings & valuation, TET or ZTF?

Treatt has higher earnings, but lower revenue than Zotefoams. Zotefoams is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Treatt £128.29M 1.40 £11.22M £7.22 42.24 Zotefoams £176.29M 1.21 £9.80M £44.87 9.69

Is TET or ZTF more profitable?

Zotefoams has a net margin of 14.28% compared to Treatt's net margin of 3.40%. Zotefoams' return on equity of 18.25% beat Treatt's return on equity. Company Net Margins Return on Equity Return on Assets Treatt 3.40% 3.22% 6.72% Zotefoams 14.28% 18.25% 5.48%

Which has better valuation and earnings, SYNT or ZTF?

Zotefoams has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Synthomer £1.80B 0.11 -£82.04M -£96.00 N/A Zotefoams £176.29M 1.21 £9.80M £44.87 9.69

Is SYNT or ZTF more profitable?

Zotefoams has a net margin of 14.28% compared to Synthomer's net margin of -6.81%. Zotefoams' return on equity of 18.25% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Synthomer -6.81% -13.27% -0.28% Zotefoams 14.28% 18.25% 5.48%

Does the media refer more to SYNT or ZTF?

In the previous week, Synthomer had 7 more articles in the media than Zotefoams. MarketBeat recorded 16 mentions for Synthomer and 9 mentions for Zotefoams. Zotefoams' average media sentiment score of 0.40 beat Synthomer's score of 0.29 indicating that Zotefoams is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Synthomer 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Zotefoams 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Zotefoams (ZTF) Competitors

GBX 435 +15.00 (+3.57%)

As of 07:22 AM Eastern

Compare

ZTF vs. VCT, SCPA, ESNT, TET, and SYNT

Should you buy Zotefoams stock or one of its competitors? MarketBeat compares Zotefoams with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Zotefoams include Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Treatt (TET), and Synthomer (SYNT).

How does Zotefoams compare to Victrex?

Zotefoams (LON:ZTF) and Victrex (LON:VCT) are both small-cap materials companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment.

Victrex has higher revenue and earnings than Zotefoams. Victrex is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£176.29M	1.21	£9.80M	£44.87	9.69
Victrex	£296.40M	2.43	£30.80M	-£22.40	N/A

Zotefoams has a net margin of 14.28% compared to Victrex's net margin of -6.70%. Zotefoams' return on equity of 18.25% beat Victrex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	14.28%	18.25%	5.48%
Victrex	-6.70%	-4.95%	6.59%

28.9% of Zotefoams shares are held by institutional investors. Comparatively, 75.5% of Victrex shares are held by institutional investors. 4.5% of Zotefoams shares are held by insiders. Comparatively, 4.2% of Victrex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Zotefoams has a beta of 1.239, meaning that its stock price is 24% more volatile than the broader market. Comparatively, Victrex has a beta of 0.774, meaning that its stock price is 23% less volatile than the broader market.

In the previous week, Zotefoams had 8 more articles in the media than Victrex. MarketBeat recorded 9 mentions for Zotefoams and 1 mentions for Victrex. Zotefoams' average media sentiment score of 0.40 beat Victrex's score of 0.00 indicating that Zotefoams is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zotefoams	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Victrex	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Zotefoams pays an annual dividend of GBX 7.60 per share and has a dividend yield of 1.7%. Victrex pays an annual dividend of GBX 59.56 per share and has a dividend yield of 7.2%. Zotefoams pays out 16.9% of its earnings in the form of a dividend. Victrex pays out -265.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Victrex is clearly the better dividend stock, given its higher yield and lower payout ratio.

Zotefoams presently has a consensus target price of GBX 605, suggesting a potential upside of 39.08%. Victrex has a consensus target price of GBX 663.33, suggesting a potential downside of 19.79%. Given Zotefoams' stronger consensus rating and higher probable upside, analysts plainly believe Zotefoams is more favorable than Victrex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Victrex	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Summary

Zotefoams beats Victrex on 11 of the 18 factors compared between the two stocks.

How does Zotefoams compare to Scapa Group?

Scapa Group (LON:SCPA) and Zotefoams (LON:ZTF) are both small-cap materials companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.

Zotefoams has lower revenue, but higher earnings than Scapa Group. Scapa Group is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scapa Group	£281.80M	0.00	N/A	-£29.30	N/A
Zotefoams	£176.29M	1.21	£9.80M	£44.87	9.69

Zotefoams has a net margin of 14.28% compared to Scapa Group's net margin of 0.00%. Zotefoams' return on equity of 18.25% beat Scapa Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Scapa Group	N/A	N/A	N/A
Zotefoams	14.28%	18.25%	5.48%

Zotefoams has a consensus price target of GBX 605, suggesting a potential upside of 39.08%. Given Zotefoams' stronger consensus rating and higher probable upside, analysts plainly believe Zotefoams is more favorable than Scapa Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scapa Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

28.9% of Zotefoams shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Zotefoams had 9 more articles in the media than Scapa Group. MarketBeat recorded 9 mentions for Zotefoams and 0 mentions for Scapa Group. Zotefoams' average media sentiment score of 0.40 beat Scapa Group's score of 0.00 indicating that Zotefoams is being referred to more favorably in the news media.

Company	Overall Sentiment
Scapa Group	Neutral
Zotefoams	Neutral

Summary

Zotefoams beats Scapa Group on 12 of the 13 factors compared between the two stocks.

How does Zotefoams compare to Essentra?

Zotefoams (LON:ZTF) and Essentra (LON:ESNT) are related small-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

Zotefoams currently has a consensus price target of GBX 605, suggesting a potential upside of 39.08%. Essentra has a consensus price target of GBX 132.50, suggesting a potential upside of 17.04%. Given Zotefoams' stronger consensus rating and higher probable upside, equities research analysts plainly believe Zotefoams is more favorable than Essentra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Essentra	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Zotefoams pays an annual dividend of GBX 7.60 per share and has a dividend yield of 1.7%. Essentra pays an annual dividend of GBX 2 per share and has a dividend yield of 1.8%. Zotefoams pays out 16.9% of its earnings in the form of a dividend. Essentra pays out 80.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Zotefoams has higher earnings, but lower revenue than Essentra. Zotefoams is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£176.29M	1.21	£9.80M	£44.87	9.69
Essentra	£315.70M	1.02	£3.50M	£2.50	45.28

Zotefoams has a beta of 1.239, meaning that its stock price is 24% more volatile than the broader market. Comparatively, Essentra has a beta of 0.829, meaning that its stock price is 17% less volatile than the broader market.

Zotefoams has a net margin of 14.28% compared to Essentra's net margin of 1.71%. Zotefoams' return on equity of 18.25% beat Essentra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	14.28%	18.25%	5.48%
Essentra	1.71%	2.02%	1.74%

In the previous week, Zotefoams had 8 more articles in the media than Essentra. MarketBeat recorded 9 mentions for Zotefoams and 1 mentions for Essentra. Zotefoams' average media sentiment score of 0.40 beat Essentra's score of 0.36 indicating that Zotefoams is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zotefoams	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Essentra	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

28.9% of Zotefoams shares are owned by institutional investors. Comparatively, 69.5% of Essentra shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by company insiders. Comparatively, 0.5% of Essentra shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Zotefoams beats Essentra on 13 of the 17 factors compared between the two stocks.

How does Zotefoams compare to Treatt?

Treatt (LON:TET) and Zotefoams (LON:ZTF) are both small-cap materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, media sentiment and dividends.

17.5% of Treatt shares are held by institutional investors. Comparatively, 28.9% of Zotefoams shares are held by institutional investors. 4.1% of Treatt shares are held by company insiders. Comparatively, 4.5% of Zotefoams shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Treatt currently has a consensus target price of GBX 248.33, indicating a potential downside of 18.58%. Zotefoams has a consensus target price of GBX 605, indicating a potential upside of 39.08%. Given Zotefoams' stronger consensus rating and higher probable upside, analysts clearly believe Zotefoams is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Treatt has higher earnings, but lower revenue than Zotefoams. Zotefoams is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treatt	£128.29M	1.40	£11.22M	£7.22	42.24
Zotefoams	£176.29M	1.21	£9.80M	£44.87	9.69

Treatt has a beta of 0.907, indicating that its stock price is 9% less volatile than the broader market. Comparatively, Zotefoams has a beta of 1.239, indicating that its stock price is 24% more volatile than the broader market.

Zotefoams has a net margin of 14.28% compared to Treatt's net margin of 3.40%. Zotefoams' return on equity of 18.25% beat Treatt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treatt	3.40%	3.22%	6.72%
Zotefoams	14.28%	18.25%	5.48%

Treatt pays an annual dividend of GBX 5.60 per share and has a dividend yield of 1.8%. Zotefoams pays an annual dividend of GBX 7.60 per share and has a dividend yield of 1.7%. Treatt pays out 77.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Zotefoams pays out 16.9% of its earnings in the form of a dividend.

In the previous week, Zotefoams had 9 more articles in the media than Treatt. MarketBeat recorded 9 mentions for Zotefoams and 0 mentions for Treatt. Zotefoams' average media sentiment score of 0.40 beat Treatt's score of 0.00 indicating that Zotefoams is being referred to more favorably in the news media.

Company	Overall Sentiment
Treatt	Neutral
Zotefoams	Neutral

Summary

Zotefoams beats Treatt on 13 of the 18 factors compared between the two stocks.

How does Zotefoams compare to Synthomer?

Synthomer (LON:SYNT) and Zotefoams (LON:ZTF) are both small-cap materials companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

Synthomer presently has a consensus price target of GBX 119, indicating a potential upside of 1.74%. Zotefoams has a consensus price target of GBX 605, indicating a potential upside of 39.08%. Given Zotefoams' stronger consensus rating and higher probable upside, analysts clearly believe Zotefoams is more favorable than Synthomer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

14.9% of Synthomer shares are held by institutional investors. Comparatively, 28.9% of Zotefoams shares are held by institutional investors. 5.0% of Synthomer shares are held by company insiders. Comparatively, 4.5% of Zotefoams shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Synthomer has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market. Comparatively, Zotefoams has a beta of 1.239, suggesting that its share price is 24% more volatile than the broader market.

Zotefoams has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Zotefoams, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synthomer	£1.80B	0.11	-£82.04M	-£96.00	N/A
Zotefoams	£176.29M	1.21	£9.80M	£44.87	9.69

Zotefoams has a net margin of 14.28% compared to Synthomer's net margin of -6.81%. Zotefoams' return on equity of 18.25% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synthomer	-6.81%	-13.27%	-0.28%
Zotefoams	14.28%	18.25%	5.48%

In the previous week, Synthomer had 7 more articles in the media than Zotefoams. MarketBeat recorded 16 mentions for Synthomer and 9 mentions for Zotefoams. Zotefoams' average media sentiment score of 0.40 beat Synthomer's score of 0.29 indicating that Zotefoams is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Synthomer	4 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
Zotefoams	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Zotefoams beats Synthomer on 13 of the 16 factors compared between the two stocks.

Get Zotefoams News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ZTF vs. The Competition

Export

Metric	Zotefoams	Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£213.94M	£11.40B	£4.90B	£2.89B
Dividend Yield	1.90%	2.81%	4.69%	6.11%
P/E Ratio	9.69	20.73	21.08	368.59
Price / Sales	1.21	53.21	5,213.24	83,687.67
Price / Cash	18.87	15.52	24.63	27.89
Price / Book	1.76	3.73	8.81	7.26
Net Income	£9.80M	£223.51M	£154.73M	£5.89B
7 Day Performance	-4.19%	2.20%	6.86%	1.65%
1 Month Performance	-1.58%	3.25%	5.23%	2.43%
1 Year Performance	20.83%	22.30%	43.35%	74.99%

Zotefoams Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ZTF Zotefoams	4.1141 of 5 stars	GBX 435 +3.6%	GBX 605 +39.1%	+16.7%	£213.94M	£176.29M	9.69	549	Earnings Report
VCT Victrex	0.5459 of 5 stars	GBX 787.05 +1.2%	GBX 663.33 -15.7%	+19.6%	£685.71M	£296.40M	N/A	1,109
SCPA Scapa Group	N/A	N/A	N/A	N/A	£402.98M	£281.80M	N/A	1,461
ESNT Essentra	1.9404 of 5 stars	GBX 106 -0.9%	GBX 132.50 +25.0%	+9.6%	£300.47M	£315.70M	151.43	350	Gap Down
TET Treatt	N/A	GBX 305 flat	GBX 248.33 -18.6%	N/A	£180.06M	£128.29M	42.24	350

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:ZTF) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Zotefoams (ZTF) Competitors